95 related articles for article (PubMed ID: 21112858)
1. Multiple endocrine neoplasia 2: providing care for the family.
Mahon SM; Waldman L
Clin J Oncol Nurs; 2010 Dec; 14(6):803-6. PubMed ID: 21112858
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia 1: providing care for the family.
Mahon SM; Waldman L
Clin J Oncol Nurs; 2010 Oct; 14(5):657-60. PubMed ID: 20880824
[TBL] [Abstract][Full Text] [Related]
3. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
[TBL] [Abstract][Full Text] [Related]
4. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
5. [Lump in the neck: 4 patients with a medullary thyroid carcinoma].
Jansen M; Jansen-Schillhorn van Veen JM; Vroom TM; van Vroonhoven TJ; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2234-41. PubMed ID: 11757248
[TBL] [Abstract][Full Text] [Related]
6. Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer.
Rubinstein WS
Hematol Oncol Clin North Am; 2010 Oct; 24(5):907-37. PubMed ID: 20816580
[TBL] [Abstract][Full Text] [Related]
7. [Multiple endocrine neoplasia type 2a and 2b].
Vestergaard P
Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
9. [Multiple endocrine neoplasia type IIa].
Sćepanović D; Bajić N; Kadić R; Popović-Brkić V
Srp Arh Celok Lek; 1994; 122(7-8):234-6. PubMed ID: 17974396
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of multiple endocrine neoplasia Type 2.
Bugalho MJ; Domingues R; Sobrinho L
Expert Rev Mol Diagn; 2003 Nov; 3(6):769-79. PubMed ID: 14628904
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic expression of a mutation in MEN 2A documented in a family in the western part of Sweden].
Lindskog S; Ahlman H; Illerskog A; Nilsson O; Nilsson B; Tisell LE; Ysander L; Jansson S
Lakartidningen; 2001 Aug; 98(35):3690-1, 3694-5. PubMed ID: 11577645
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
14. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
[TBL] [Abstract][Full Text] [Related]
15. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
16. [Ret-protooncogene mutation, verified by molecular genetic methods, in a Hungarian MEN Type 2a family].
Igaz P; Rácz K; Tóth M; Cserepes E; Esik O; Kiss R; Perner F; Gláz E; Tulassay Z
Orv Hetil; 1999 Feb; 140(7):355-7. PubMed ID: 10091505
[TBL] [Abstract][Full Text] [Related]
17. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
Erdogan MF; Gursoy A
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular aspects of multiple endocrine neoplasia.
Wick MJ
Clin Lab Med; 1997 Mar; 17(1):39-57. PubMed ID: 9138898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]